scholarly article | Q13442814 |
P50 | author | Peter J. Hotez | Q7174738 |
Maria Elena Bottazzi | Q28817215 | ||
Ricardo T. Fujiwara | Q30513841 | ||
Ulrich Strych | Q37375246 | ||
Bin Zhan | Q85367926 | ||
Junfei Wei | Q91178810 | ||
Coreen Beaumier | Q91178814 | ||
Brian C. Keegan | Q96694278 | ||
Leroy Versteeg | Q114440460 | ||
Ana Clara Gazzinelli-Guimarães | Q114440461 | ||
Zhuyun Liu | Q114780922 | ||
Neima Briggs | Q56419193 | ||
Kathryn J. Jones | Q84356873 | ||
P2860 | cites work | Effect of sanitation on soil-transmitted helminth infection: systematic review and meta-analysis | Q21092320 |
Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin, and school performance | Q24186330 | ||
Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis | Q24657081 | ||
Current status of vaccines for schistosomiasis | Q24657733 | ||
Cholera Toxin Subunit B as Adjuvant--An Accelerator in Protective Immunity and a Break in Autoimmunity | Q26782576 | ||
Advancing a multivalent 'Pan-anthelmintic' vaccine against soil-transmitted nematode infections | Q27023470 | ||
Vaccination of Gerbils with Bm-103 and Bm-RAL-2 Concurrently or as a Fusion Protein Confers Consistent and Improved Protection against Brugia malayi Infection | Q27303702 | ||
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015 | Q27468570 | ||
TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review | Q28066798 | ||
The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice | Q28552440 | ||
Helminth elimination in the pursuit of sustainable development goals: a "worm index" for human development | Q28648184 | ||
Phylogeny.fr: robust phylogenetic analysis for the non-specialist | Q29547666 | ||
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30353189 | ||
Ac-SAA-1, an immunodominant 16 kDa surface-associated antigen of infective larvae and adults of Ancylostoma caninum | Q33206016 | ||
A recombinant enolase from Anisakis simplex is differentially recognized in natural human and mouse experimental infections | Q33220496 | ||
The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases | Q33945536 | ||
Intranasal immunization with recombinant Ascaris suum 14-kilodalton antigen coupled with cholera toxin B subunit induces protective immunity to A. suum infection in mice | Q34009585 | ||
Animal models of intestinal nematode infections of humans | Q34270038 | ||
Granulocyte-macrophage colony-stimulating factor: not just another haematopoietic growth factor. | Q34387000 | ||
Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans | Q34492595 | ||
Mass deworming to improve developmental health and wellbeing of children in low-income and middle-income countries: a systematic review and network meta-analysis | Q34547179 | ||
Immunity to helminths: resistance, regulation, and susceptibility to gastrointestinal nematodes | Q35532700 | ||
Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175. | Q35557657 | ||
IFNγ and IL-12 Restrict Th2 Responses during Helminth/Plasmodium Co-Infection and Promote IFNγ from Th2 Cells | Q35683659 | ||
Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16. | Q35690054 | ||
Mice intranasally immunized with a recombinant 16-kilodalton antigen from roundworm Ascaris parasites are protected against larval migration of Ascaris suum | Q35802015 | ||
The immunobiology of Th1 polarization in high-pathology schistosomiasis | Q35884229 | ||
Multiple Exposures to Ascaris suum Induce Tissue Injury and Mixed Th2/Th17 Immune Response in Mice. | Q35905396 | ||
Protective immune mechanisms in helminth infection | Q36481763 | ||
Hookworm vaccines: past, present, and future | Q36635886 | ||
Interleukin 2 plays a central role in Th2 differentiation. | Q37095134 | ||
Rapid re-infection with soil-transmitted helminths after triple-dose albendazole treatment of school-aged children in Yunnan, People's Republic of China | Q37107970 | ||
Germinal Center B Cell and T Follicular Helper Cell Responses to Viral Vector and Protein-in-Adjuvant Vaccines. | Q37153663 | ||
Soil-transmitted helminthiases: number of children treated in 2011 | Q95530360 | ||
Biophysical and formulation studies of the Schistosoma mansoni TSP-2 extracellular domain recombinant protein, a lead vaccine candidate antigen for intestinal schistosomiasis | Q37694861 | ||
The Human Hookworm Vaccine | Q37706375 | ||
Regulatory T cells and immune regulation of allergic diseases: roles of IL-10 and TGF-β. | Q38233294 | ||
Widespread anthelmintic resistance in European farmed ruminants: a systematic review. | Q38374595 | ||
Eosinophils in Helminth Infection: Defenders and Dupes | Q38855142 | ||
The Regulatory Function of Eosinophils | Q38990422 | ||
Vaccination with irradiated Ancylostoma caninum third stage larvae induces a Th2 protective response in dogs | Q39013779 | ||
Expression, purification, and molecular analysis of the Necator americanus glutathione S-transferase 1 (Na-GST-1): a production process developed for a lead candidate recombinant hookworm vaccine antigen | Q39030020 | ||
Cloning, yeast expression, isolation, and vaccine testing of recombinant Ancylostoma-secreted protein (ASP)-1 and ASP-2 from Ancylostoma ceylanicum | Q39030027 | ||
Human anthelminthic vaccines: Rationale and challenges | Q39078215 | ||
Transferring Luminex® cytokine assays to a wall-less plate technology: Validation and comparison study with plasma and cell culture supernatants | Q39191307 | ||
Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice | Q39219558 | ||
The development of a mouse model to explore resistance and susceptibility to early Ascaris suum infection | Q40383128 | ||
A phase 1, open-label, randomized study to compare the immunogenicity and safety of different administration routes and doses of virosomal influenza vaccine in elderly | Q40527989 | ||
Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing. | Q41126741 | ||
Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis | Q41840474 | ||
Sequence analysis of Bs-Ag2 gene from Baylisascaris schroederi of giant panda and evaluation of the efficacy of a recombinant Bs-Ag2 antigen in mice | Q42620527 | ||
Ascaris suum enolase is a potential vaccine candidate against ascariasis | Q42642282 | ||
Molecular cloning and partial characterization of a nematode-specific 24 kDa protein from Ascaris suum | Q42647444 | ||
Oral immunogenicity and protective efficacy in mice of transgenic rice plants producing a vaccine candidate antigen (As16) of Ascaris suum fused with cholera toxin B subunit | Q43521889 | ||
Comparative analyses of the complete mitochondrial genomes of Ascaris lumbricoides and Ascaris suum from humans and pigs | Q44479647 | ||
Generalized urticaria induced by the Na-ASP-2 hookworm vaccine: implications for the development of vaccines against helminths | Q47709317 | ||
Cloning and characterisation of a highly immunoreactive 37 kDa antigen with multi-immunoglobulin domains from the swine roundworm Ascaris suum | Q48270855 | ||
Pig Ascaris: an important source of human ascariasis in China | Q48636854 | ||
[Construction of expression vector of ALAg and immune protection of its recombinant protein induced in mice]. | Q54336280 | ||
Parasitological and immunological aspects of early Ascaris spp. infection in mice | Q58853079 | ||
Active immunization against Ascaris suum minimum lethal dose in mice | Q70501479 | ||
Role of IL-5 in innate and adaptive immunity to larval Strongyloides stercoralis in mice | Q73086249 | ||
Lung-stage protein profile and antigenic relationship between Ascaris lumbricoides and Ascaris suum | Q74663703 | ||
Parasite-induced Th2 polarization is associated with down-regulated dendritic cell responsiveness to Th1 stimuli and a transient delay in T lymphocyte cycling | Q80418667 | ||
Recombinant Ascaris 16-Kilodalton protein-induced protection against Ascaris suum larval migration after intranasal vaccination in pigs | Q80895998 | ||
Vaccination with recombinant Ascaris suum 24-kilodalton antigen induces a Th1/Th2-mixed type immune response and confers high levels of protection against challenged Ascaris suum lung-stage infection in BALB/c mice | Q81926362 | ||
Production of Ascaris suum As14 protein and its fusion protein with cholera toxin B subunit in rice seeds | Q84343543 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Ascaris suum | Q2062253 |
P304 | page(s) | e0005769 | |
P577 | publication date | 2017-07-14 | |
P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
P1476 | title | Yeast-expressed recombinant As16 protects mice against Ascaris suum infection through induction of a Th2-skewed immune response | |
P478 | volume | 11 |
Q90699172 | CD4+ Th immunogenicity of the Ascaris spp. secreted products |
Q59340996 | IgG Induced by Vaccination With Extracts Is Protective Against Infection |
Q89695500 | Protective immunity elicited by the nematode-conserved As37 recombinant protein against Ascaris suum infection |
Q58697748 | Trichuris muris whey acidic protein induces type 2 protective immunity against whipworm |
Q103041602 | Vaccination with chimeric protein induces protection in murine model against ascariasis |
Q95936551 | Whipworm and roundworm infections |
Search more.